This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Dec 1;57(6):904-5.

doi: 10.1002/pbc.23178. Epub 2011 Apr 29.

Sirolimus for refractory vascular anomalies

Cameron C Trenor 3rd¹

Affiliations

Affiliation

¹ Division of Hematology/Oncology, Vascular Anomalies Center, Children's Hospital Boston and Dana-Farber Cancer Institute, 300 Longwood Avenue, Boston, Massachusetts 02115, USA. Cameron.trenor@childrens.harvard.edu

PMID: 21538825
DOI: 10.1002/pbc.23178

Comment

Sirolimus for refractory vascular anomalies

Cameron C Trenor 3rd. Pediatr Blood Cancer. 2011.

. 2011 Dec 1;57(6):904-5.

doi: 10.1002/pbc.23178. Epub 2011 Apr 29.

Author

Cameron C Trenor 3rd¹

Affiliation

¹ Division of Hematology/Oncology, Vascular Anomalies Center, Children's Hospital Boston and Dana-Farber Cancer Institute, 300 Longwood Avenue, Boston, Massachusetts 02115, USA. Cameron.trenor@childrens.harvard.edu

PMID: 21538825
DOI: 10.1002/pbc.23178

No abstract available

PubMed Disclaimer

Comment on

Sirolimus for the treatment of complicated vascular anomalies in children.
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Hammill AM, et al. Pediatr Blood Cancer. 2011 Dec 1;57(6):1018-24. doi: 10.1002/pbc.23124. Epub 2011 Mar 28. Pediatr Blood Cancer. 2011. PMID: 21445948

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley